Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines

NCT01547923 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1142

Enrollment

OTHER

Sponsor class

Stopped The study stopped due to a death in the arm control

Conditions

Colorectal Cancer
Intravenous 5 Fluorouracile

Interventions

GENETIC: Blood sample for phenotypic and pharmacogenetic analysis.
GENETIC: Blood sample for phenotypic and pharmacogenetic analysis.

Sponsor

Institut Cancerologie de l'Ouest